Regarding CTD-PAH specifically, a study comprising 33 patients with this condition showed that hs-cTnT was able to risk-stratify patients with CTD-PAH for future heart failure hospitalisation and death [173]. This evidence concerns the gene TNNT2 and pulmonary arterial hypertension.